Evidence map›Paper›PMID 27995649›Full record

ArticleBritish journal of clinical pharmacology2017

Prediction of serum theophylline concentrations and cytochrome P450 1A2 activity by analyzing urinary metabolites in preterm infants.

Jin A Sohn, Han-Suk Kim, Jaeseong Oh, Joo-Youn Cho, Kyung-Sang Yu, Juyoung Lee, Seung Han Shin, Jin A Lee, Chang Won Choi, Ee-Kyung Kim and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in British journal of clinical pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Jin A SohnDepartment of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea.
Han-Suk KimDepartment of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea.
Jaeseong OhDepartment of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
Joo-Youn ChoDepartment of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
Kyung-Sang YuDepartment of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
Juyoung LeeDepartment of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea.
Seung Han ShinDepartment of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea.
Jin A LeeDepartment of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea.
Chang Won ChoiDepartment of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea.
Ee-Kyung KimDepartment of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea.
Beyong Il KimDepartment of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea.
Eun Ae ParkDepartment of Pediatrics, Ewha Womans University School of Medicine, Seoul, South Korea.
Seoul National University · KRSeoul National University Hospital · KREwha Womans University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe purpose of this study was to explore clinical markers reflecting developmental changes in drug clearance by preterm infants.

methodsPreterm infants administered aminophylline or theophylline to treat apnoea of prematurity were enrolled in this study. Trough and one of 2 h, 4 h or 6 h post-dose blood samples and urine samples were collected during steady state, to determine the concentrations of theophylline and its targeted metabolites. CYP1A2*1C and CYP1A2*1F genotypes were analyzed. Total, renal and nonrenal clearances of theophylline were calculated, and cytochrome P450 1A2 (CYP1A2) activity was obtained from the ratio of 1-methyluric acid and 3-methylxanthine to theophylline in urine. Multiple linear regression analysis was performed to evaluate the relationships between theophylline clearance and the clinical characteristics of preterm infants.

resultsA total of 152 samples from 104 preterm infants were analyzed. A strong association between the serum trough and urine theophylline concentrations was found (P < 0.001). Total, renal and nonrenal clearances of theophylline were 0.50 ± 0.29 ml kg

conclusionsCYP1A2 activity can be monitored using noninvasive random urine samples, and it can be used to assess developmental changes in theophylline clearance by preterm infants.

Indexed as

AgingApneaBronchodilator AgentsCytochrome P-450 CYP1A2FemaleGenotypeGestational AgeHumansInfantInfant, NewbornInfant, PrematureMaleTheophyllineUric AcidXanthines1-methyluric acid3-methylxanthineBronchodilator AgentsCYP1A2 protein, humanCytochrome P-450 CYP1A2TheophyllineUric AcidXanthinescytochrome P450 1A2drug monitoringpharmacokineticspremature infantstheophylline

Identifiers

PMID27995649
PMCPMC5427230
OpenAlexW2566580808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.